Quantum-Si (QSI) Income from Continuing Operations (2020 - 2026)
Quantum-Si's (QSI) quarterly Income from Continuing Operations came in at 21671000.0 in Q1 2026, down 12.93% year-on-year from 24890454.24 in Q1 2025, and down 23.05% on a QoQ basis from 17611000.0 in Q4 2025.
Quantum-Si (QSI) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Quantum-Si (QSI) has 7 years of Income from Continuing Operations data on file, last reported at 21671000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 12.93% year-over-year to 21671000.0 in Q1 2026; TTM through Mar 2026 was 103821000.0, a 3.08% decrease from a year earlier, with the FY2025 full-year figure at 101339000.0, changed 0.33% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 21671000.0, down from 17611000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for QSI reached as high as 17611000.0 in Q4 2025 and fell as low as 35703000.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 26612882.35 across 5 years, with a median of 25313000.0 in 2024.
- Across the five-year window, Income from Continuing Operations plunged 198.62% in 2022 and surged 46.83% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 33140000.0 in 2022, then jumped by 33.47% to 22048000.0 in 2023, then tumbled by 50.22% to 33121000.0 in 2024, then surged by 46.83% to 17611000.0 in 2025, then declined by 23.05% to 21671000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 21671000.0 in Q1 2026, 17611000.0 in Q4 2025, and 35703000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quantum-Si | 171.01 Mn | 43.67 Mn | 74,000.00 | -21.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.67 Mn |
| Dec 31, 2025 | -17.61 Mn |
| Sep 30, 2025 | -35.70 Mn |
| Jun 30, 2025 | -28.84 Mn |
| Mar 31, 2025 | -19.19 Mn |
| Dec 31, 2024 | -33.12 Mn |
| Sep 30, 2024 | -25.31 Mn |
| Jun 30, 2024 | -23.10 Mn |
| Mar 31, 2024 | -19.47 Mn |
| Dec 31, 2023 | -22.05 Mn |
| Sep 30, 2023 | -24.73 Mn |
| Jun 30, 2023 | -25.57 Mn |
| Mar 31, 2023 | -23.61 Mn |
| Dec 31, 2022 | -33.14 Mn |
| Sep 30, 2022 | -31.71 Mn |
| Jun 30, 2022 | -32.41 Mn |
| Mar 31, 2022 | -35.18 Mn |
| Dec 31, 2021 | -29.42 Mn |
| Sep 30, 2021 | -18.09 Mn |
| Jun 30, 2021 | -35.70 Mn |